These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7997062)

  • 1. Age-related changes in transcriptional and posttranscriptional regulation of the dopaminergic system.
    Roth GS; Joseph JA
    Life Sci; 1994; 55(25-26):2031-5. PubMed ID: 7997062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of impaired dopaminergic function during aging.
    Roth GS; Joseph JA
    Ann N Y Acad Sci; 1994 May; 719():129-35. PubMed ID: 8010587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal alterations in dopaminergic markers in the human prefrontal cortex.
    Weickert CS; Webster MJ; Gondipalli P; Rothmond D; Fatula RJ; Herman MM; Kleinman JE; Akil M
    Neuroscience; 2007 Feb; 144(3):1109-19. PubMed ID: 17123740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transcriptional regulation of loss of rat striatal D2 dopamine receptor during aging.
    Sakata M; Farooqui SM; Prasad C
    Brain Res; 1992 Mar; 575(2):309-14. PubMed ID: 1533340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of D2 receptors during aging is partially due to decreased levels of mRNA.
    Mesco ER; Joseph JA; Blake MJ; Roth GS
    Brain Res; 1991 Apr; 545(1-2):355-7. PubMed ID: 1830509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dopaminergic mechanisms of brain aging (a review of the literature)].
    Man'kovskiĭ NB; Kuznetsova SM; Ianovich LA; Red'ko LA
    Vrach Delo; 1989 Sep; (9):83-8. PubMed ID: 2692298
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
    Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging-related dysregulation of dopamine and angiotensin receptor interaction.
    Villar-Cheda B; Dominguez-Meijide A; Valenzuela R; Granado N; Moratalla R; Labandeira-Garcia JL
    Neurobiol Aging; 2014 Jul; 35(7):1726-38. PubMed ID: 24529758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum.
    Cole AJ; Bhat RV; Patt C; Worley PF; Baraban JM
    J Neurochem; 1992 Apr; 58(4):1420-6. PubMed ID: 1347779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron-specific age-related decreases in dopamine receptor subtype mRNAs.
    Hemby SE; Trojanowski JQ; Ginsberg SD
    J Comp Neurol; 2003 Feb; 456(2):176-83. PubMed ID: 12509874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal links in the CNS: focus on dopaminergic and serotonergic regulation of striatal cholinergic neurons.
    Garattini S; Consolo S; Ladinski H
    Pol J Pharmacol Pharm; 1980; 32(2):155-64. PubMed ID: 7454621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor.
    Hwang CK; D'Souza UM; Eisch AJ; Yajima S; Lammers CH; Yang Y; Lee SH; Kim YM; Nestler EJ; Mouradian MM
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7558-63. PubMed ID: 11390978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of striatal dopamine receptors and improvement of motor performance in senescence.
    Joseph JA; Roth GS
    Ann N Y Acad Sci; 1988; 515():355-62. PubMed ID: 3284425
    [No Abstract]   [Full Text] [Related]  

  • 14. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
    Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
    Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
    Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
    Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered striatal function in a mutant mouse lacking D1A dopamine receptors.
    Drago J; Gerfen CR; Lachowicz JE; Steiner H; Hollon TR; Love PE; Ooi GT; Grinberg A; Lee EJ; Huang SP
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12564-8. PubMed ID: 7809078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarity of age-dependent changes in renal and striatal dopamine receptors.
    Mancini M; Ricci A; Zaccheo D; Amenta F
    Funct Neurol; 1991; 6(3):227-9. PubMed ID: 1835951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.
    Ritter LM; Meador-Woodruff JH
    Biol Psychiatry; 1997 Aug; 42(3):155-64. PubMed ID: 9232207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.